Lymphangiomyomatosis recurrence in the allograft after single-lung transplantation.
The evolution of lung transplantation has offered an additional treatment option for patients with a variety of end-stage lung diseases, including some with systemic disorders. Lymphangiomyomatosis (LAM) is a multisystem disease of premenopausal women. The lung is the most frequently involved vital organ, and respiratory failure is the most common case of death. A small number of patients with LAM have undergone lung transplantation. This report describes a case of recurrent LAM in the allograft after single lung transplantation and discusses the implications of this finding.
O'Brien
J D
JD
Department of Medicine, Washington University School of Medicine, St. Louis, MO 63110, USA.
Lium
J H
JH
Parosa
J F
JF
Deyoung
B R
BR
Wick
M R
MR
Trulock
E P
EP
D000328:Adult; D001228:Aspergillosis / Q000473:pathology; D005260:Female; D006801:Humans; D008168:Lung / Q000473:pathology*; D008172:Lung Diseases, Fungal / Q000473:pathology; D008175:Lung Neoplasms / Q000473:pathology* / Q000601:surgery; D016040:Lung Transplantation / Q000473:pathology*; D018192:Lymphangioleiomyomatosis / Q000473:pathology* / Q000601:surgery; D012008:Recurrence